Effects of the aldehyde dehydrogenase inhibitor disulfiram on the plasma pharmacokinetics, metabolism, and toxicity of benzaldehyde dimethane sulfonate (NSC281612, DMS612, BEN) in mice. [electronic resource]
- Cancer chemotherapy and pharmacology Dec 2013
- 1195-204 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
1432-0843
10.1007/s00280-013-2296-5 doi
Aldehyde Dehydrogenase--antagonists & inhibitors Animals Antineoplastic Agents--pharmacokinetics Area Under Curve Benzaldehydes--pharmacokinetics Chemical and Drug Induced Liver Injury--etiology Disulfiram--pharmacology Drug Interactions Enzyme Inhibitors--pharmacology Female Half-Life Mice